Does Sucralose Damage Your Skin? What the DNA and Gut-Barrier Study Actually Means for Consumers

Sucralose, the zero-calorie artificial sweetener sold as Splenda®, has not been demonstrated to damage DNA in people who consume it at typical dietary levels — but a 2023 laboratory study found that a chemically related impurity called sucralose-6-acetate broke DNA strands in cultured human cells and disrupted a model of the intestinal lining, triggering a wave of consumer concern that regulators and subsequent researchers have since worked to put in context.

Before diving into the science, here is a side-by-side summary of the key claims, what the evidence actually showed, and where the regulatory consensus currently stands:

Claim	What the evidence showed	Regulatory verdict (2026)
Sucralose-6-acetate is genotoxic	DNA-strand breaks detected in cultured human blood cells (in vitro); not demonstrated in people eating sucralose	EFSA: limited relevance for overall genotoxicity assessment; no genotoxicity concern for sucralose at authorized uses
Sucralose causes leaky gut	Both sucralose and sucralose-6-acetate increased permeability in lab gut-tissue models; not confirmed in controlled human trials at typical doses	No intestinal safety concern identified at the current ADI of 15 mg/kg bw/day
Sucralose-6-acetate forms during digestion	Originally proposed based on rat metabolite data; EFSA 2026 noted the compounds may have been pre-existing impurities, not metabolic products	Mechanism unconfirmed in humans
Everyday sucralose consumption exceeds genotoxicity thresholds	Researchers estimated trace impurity in one drink could exceed the 0.15 µg/person/day toxicological concern threshold	Threshold of toxicological concern is a screening tool, not an ADI; EFSA retained the ADI and found exposure below it
Sucralose affects appetite and blood sugar	A 2025 Nature Metabolism RCT found sucralose increased hypothalamic blood flow and hunger vs. sugar; cardiometabolic effects mixed across 23 RCTs	Separate question from DNA damage; under continued review

What exactly is sucralose-6-acetate, and why does it matter?

Sucralose-6-acetate is a chemical analogue of sucralose — not sucralose itself — that can arise as a manufacturing impurity and remain in the finished sweetener. The 2023 NC State investigation, led by adjunct professor Susan Schiffman, reported detecting it at concentrations of up to 0.67% in commercial sucralose samples. That distinction matters: the substance that showed genotoxic effects in the lab is a trace contaminant, not the primary ingredient people are consuming.

Schiffman's team had earlier published work in 2018 suggesting that fat-soluble compounds appeared in the urine and feces of rats given sucralose, which they interpreted as evidence the sweetener was being chemically transformed inside the animals. Their subsequent research identified sucralose-6-acetate as one of those compounds. The European Food Safety Authority's 2026 full reassessment, however, noted that those rat-study compounds could have been impurities already present in the administered sucralose rather than metabolic byproducts — meaning the digestion-produces-sucralose-6-acetate claim remains unconfirmed in humans.

Sucralose itself is 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-β-D-galactopyranoside, a crystalline compound derived from sucrose by replacing three hydroxyl groups with chlorine atoms. It is approximately 600–650 times sweeter than sucrose at typical concentrations, according to the European Commission's Scientific Committee on Food, and degrades primarily through simple hydrolysis rather than extensive metabolism.

What did the 2023 DNA damage study actually find?

The NC State study exposed cultured human blood cells to sucralose-6-acetate and looked for markers of genotoxicity — the capacity to damage genetic material. The researchers reported results consistent with DNA-strand breaks, a pattern associated with genotoxic substances.

"In short, we found that sucralose-6-acetate is genotoxic, and that it effectively broke up DNA in cells that were exposed to the chemical," Schiffman said when the findings were announced.

These were in vitro experiments — conducted outside a living organism, in cell cultures — not studies of people drinking sucralose-sweetened beverages. The distinction matters enormously. Exposing cells directly to a concentrated chemical can reveal a potential hazard, but it does not establish whether eating or drinking a food exposes human tissues to enough of that chemical to cause the same effect. The 2023 study did not demonstrate DNA damage from everyday sucralose consumption.

The researchers also raised a concern about exposure thresholds. The European Food Safety Authority uses a threshold of toxicological concern of 0.15 micrograms per person per day for genotoxic substances when detailed toxicity data are limited. Schiffman's team estimated that trace amounts of sucralose-6-acetate in a single daily sucralose-sweetened drink could exceed that figure. A threshold of toxicological concern, though, is a conservative screening tool — a trigger for further investigation — not an acceptable daily intake established through full toxicological review. Exceeding it does not equate to demonstrating that a drink causes DNA damage or disease in a person.

How does sucralose affect the gut barrier, and what does that mean for skin?

The gut-barrier findings from the 2023 study are the part most relevant to readers interested in skin health. The intestinal epithelium — the single-cell-thick lining of the gut wall — is the primary physical barrier preventing undigested food particles, bacteria, and metabolic byproducts from passing directly into the bloodstream. When that barrier becomes more permeable than normal, the condition is commonly called "leaky gut."

Using a laboratory system containing human intestinal tissue, the NC State team tested both sucralose and sucralose-6-acetate. Both impaired barrier integrity under experimental conditions, specifically damaging the tight junctions where epithelial cells connect. Gut cells exposed to sucralose-6-acetate also showed increased activity in genes associated with oxidative stress, inflammation, and carcinogenicity.

The skin connection runs through systemic inflammation. Increased gut permeability has been theorized — though not conclusively proven — to allow inflammatory molecules and bacterial fragments such as lipopolysaccharides to enter circulation, contributing to inflammatory skin conditions including acne, eczema, and rosacea. This is a plausible biological pathway, but the chain of causation from "sucralose-6-acetate in a lab tissue model increases gut permeability" to "drinking diet soda worsens your skin" involves several unproven steps.

What the gut-barrier experiment did not do: it did not measure whether people consuming sucralose at typical dietary levels experience measurable changes in intestinal permeability, nor did it follow participants to see whether any skin outcomes changed. Those are the studies that would be needed to support a direct dietary warning for skin health.

A 2020 randomized, double-blinded crossover clinical trial published in Nutrients found that daily consumption of sucralose at 20% of the acceptable daily intake for 14 days had minimal effect on gut microbiota composition or short-chain fatty acid production in healthy adults. A 2022 review in the same journal concluded that while animal and in vitro studies suggest dose-dependent microbiota changes, most short-term human interventions with sucralose below the ADI found no significant effect on bacterial groups, though it called for longer-term human studies accounting for baseline microbiota differences.

What did the 2026 EFSA safety review conclude?

In February 2026, the European Food Safety Authority published a full re-evaluation of sucralose as a food additive. Its conclusions are the most authoritative regulatory statement currently available:

The acceptable daily intake of 15 milligrams per kilogram of body weight per day was retained. This ADI is the amount considered safe to consume every day over a lifetime, established after reviewing the full toxicological database.
Estimated dietary exposure across all assessed population groups remained below that ADI.
The panel reviewed the 2023 sucralose-6-acetate research and the DNA damage signals it reported, but judged the screening evidence to have limited relevance for the overall genotoxicity assessment.
After weighing laboratory, animal, and human evidence, the panel concluded that sucralose's use as a food additive did not raise a genotoxicity concern.

The EFSA review did identify one unresolved issue: under some prolonged high-temperature conditions, chlorine from sucralose may become incorporated into other compounds whose health effects are uncertain. For that reason, the panel could not confirm the safety of expanding sucralose use in certain baked goods. This concern relates to thermal degradation products rather than the impurity studied by Schiffman's team and is a separate matter from the sucralose-6-acetate DNA-damage question.

In the United States, sucralose remains approved by the Food and Drug Administration, whose safety assessment included more than 110 studies addressing potential toxic effects, along with human clinical research.

What did later genetic toxicity testing of commercial sucralose find?

A study published in Food and Chemical Toxicology in August 2026 evaluated commercial-grade sucralose using multiple genetic toxicity assays in cells and animals. The authors reported negative results in most tests, including assays for gene mutations and chromosome damage. A study in genetically modified mice also found no increase in the mutations being measured.

One test — a comet assay — did detect DNA damage signals in several tissues. The authors described complications in interpreting those results and concluded that the overall findings did not indicate genotoxicity. Several authors were affiliated with Tate & Lyle (a major sucralose manufacturer) and others with Intertek, making the study's industry connections relevant context for readers evaluating its conclusions.

Critically, this 2026 study tested commercial sucralose rather than isolated sucralose-6-acetate, so it addresses a related but not identical question to the 2023 research. The two bodies of work are not directly contradictory — they examined different substances under different conditions.

Does sucralose affect appetite or blood sugar in ways that could affect skin?

Separate from the DNA-damage question, researchers have examined whether sucralose influences appetite signaling and metabolic responses — both of which have indirect relevance to skin health through hormonal and inflammatory pathways.

A randomized study published in Nature Metabolism in March 2025 enrolled 75 young adults who consumed drinks containing sucralose, an equally sweet amount of sugar, or water on separate visits. Compared with sugar, sucralose increased reported hunger and blood flow in the hypothalamus, the brain region involved in appetite regulation. Compared with water, it increased hypothalamic blood flow but did not change hunger ratings. These were acute responses measured on the day of consumption — not evidence that sucralose caused lasting weight gain or metabolic disruption.

A systematic review published in August 2026 examined 23 randomized trials of sucralose and cardiometabolic outcomes in healthy adults. Results for blood sugar regulation were mixed: some studies reported unfavorable changes, while others found no effect. The review's authors raised concerns about possible metabolic effects, and questions about appetite and glucose regulation remain distinct from the original claim about DNA damage.

For skin specifically, chronically elevated blood glucose is associated with glycation — a process by which sugar molecules bind to collagen and elastin fibers, reducing their flexibility and contributing to accelerated skin aging. Whether sucralose, which does not raise blood glucose the way table sugar does, could contribute to glycation-related skin changes through indirect metabolic pathways is speculative at this stage. No study has directly measured sucralose's effect on skin collagen or dermal aging markers.

What does this mean for consumers who care about skin health?

The current evidence does not support a blanket warning that sucralose damages skin. What it does support is a more detailed picture.

The 2023 study identified a real and important laboratory signal — sucralose-6-acetate, a trace impurity, broke DNA strands in cultured cells and increased gut tissue permeability. Those findings are worth taking seriously as a basis for further research. They are not, however, equivalent to evidence that drinking a diet soda harms the skin or gut of a living person.

The 2026 EFSA reassessment, the most thorough regulatory review of sucralose to date, retained the existing safety standard and found no genotoxicity concern at authorized use levels. That conclusion does not mean sucralose is without any open questions — the heating concern and ongoing metabolic research keep the picture from being fully closed — but it does mean that the alarming 2023 headlines overstated what the data showed.

For people with inflammatory skin conditions such as acne or rosacea, where gut-skin axis research is an active area of investigation, the gut-barrier findings are worth monitoring as the science develops. Acting on them now by eliminating sucralose would be getting ahead of the evidence. The more established dietary levers for skin inflammation — overall sugar load, ultra-processed food intake, omega-3 to omega-6 ratio, and fiber intake supporting microbiome diversity — have considerably stronger human evidence behind them.

Consuming sucralose within normal dietary ranges (well below the 15 mg/kg/day ADI), the current regulatory and scientific consensus does not indicate a skin or DNA damage risk. Choosing to reduce intake over unresolved questions around heating or long-term metabolic effects is a reasonable personal decision, but it should be framed as precaution, not as a response to confirmed harm.

How does sucralose compare to other sweeteners on safety and skin relevance?

Sucralose is not the only artificial sweetener with open questions. Aspartame was classified as "possibly carcinogenic to humans" (Group 2B) by the International Agency for Research on Cancer in 2023 — a classification that reflects limited evidence and is shared with substances like aloe vera extract and pickled vegetables, not a finding of confirmed carcinogenicity. Saccharin, once thought to cause bladder cancer in rodents, was removed from the U.S. list of anticipated carcinogens in 2000 after the mechanism was found not to apply to humans.

The 2022 review on sucralose and saccharin noted that in vitro and animal studies suggest dose-dependent microbiota changes for both sweeteners, but that most short-term human interventions below the ADI found no significant effect. The pattern — concerning signals in cell and animal models, limited confirmation in human trials at realistic doses — is consistent across the class.

For skin-focused consumers, the most relevant consideration across all sweeteners is whether their use is displacing whole-food alternatives that actively support skin health (such as fruit, which provides antioxidants and fiber alongside natural sugars) rather than whether the sweetener itself is directly damaging skin tissue. That framing keeps the evidence in proportion.

The bottom line on sucralose and skin

Sucralose-6-acetate is genotoxic in laboratory cell systems — that finding from the 2023 NC State study stands and has not been retracted. What subsequent research and the 2026 EFSA review have clarified is that this laboratory result does not translate directly into a demonstrated health risk for people consuming sucralose at typical dietary levels. The impurity's presence at up to 0.67% in some commercial samples, the unconfirmed claim that digestion produces meaningful amounts of it in humans, and the gap between cell-culture effects and whole-body outcomes all limit how far the 2023 findings can be extrapolated.

Skin health sits at the end of a long causal chain from sweetener consumption, and that chain currently has too many unproven links to support specific dietary guidance about sucralose and skin. The gut-barrier findings are the most plausible indirect pathway, and they warrant continued human research — particularly in people with existing inflammatory skin conditions. Until that research exists, the evidence supports informed caution rather than alarm.